In Cell Therapy, processes such as Lead Discovery, Bioprocess Optimization, and Biomarker Development for the clinic, are all made more complex by the living T cells that form the basis for the therapeutic product. IsoPlexis’ next generation systems provide actionable potency, safety, and patient-difference metrics by detecting highly potent single-cell functional subsets for the first time. We invite you to hear from some of the leaders in the field and see some of our immunotherapy data to see where our fast moving space is headed!
Sponsored by:
The post Polyfunctional Strength Offers a New Approach to Defining Quality in Cell Therapy appeared first on GEN – Genetic Engineering and Biotechnology News.
